PT-141

Browse the Research Peptides & Proteins catalog to compare individual materials and labeled vial amounts.

Review documentation for the exact product and lot, including the labeled vial amount and the scope of analytical testing. If the report for your lot is not listed in the COA directory, request it from Vertex Labs before selecting the material for your laboratory project.

Review available batch documentation through the
Vertex Labs COA database.
Additional information regarding laboratory review procedures, documentation standards, and quality controls is available on our
Testing Standards page.

PT-141 10 mg should be handled using established laboratory practices and appropriate internal quality procedures. Personnel should review the labeled strength, product labeling, batch-specific documentation, container condition, and applicable storage requirements before use in a controlled laboratory environment.

Keep the vial sealed until required for laboratory preparation and store the material according to the conditions specified on the product label. Laboratories should maintain appropriate handling, documentation, and material-control procedures for their research environment.

PT-141 is identified by its defined cyclic peptide sequence, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, associated molecular characteristics, and labeled 10 mg fill amount. These identifiers help distinguish the material from other synthetic peptide research compounds and support accurate documentation within controlled laboratory environments.

Researchers should verify the 10 mg strength, vial labeling, batch number, sequence information, and corresponding analytical documentation before use. Maintaining clear material identification and batch traceability supports consistency across laboratory workflows.